These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28139560)

  • 21. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
    Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
    Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.
    Fu X; Cui QQ; Ning JP; Fu SS; Liao XH
    Med Sci Monit; 2015 Nov; 21():3467-73. PubMed ID: 26558428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease].
    Mukhin NA; Milovanov YS; Kozlovskaya LV; Dobrosmyslov IA; Milovanova LY
    Ter Arkh; 2016; 88(4):41-45. PubMed ID: 27070162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.
    Wohlfahrt P; Melenovsky V; Kotrc M; Benes J; Jabor A; Franekova J; Lemaire S; Kautzner J; Jarolim P
    JACC Heart Fail; 2015 Oct; 3(10):829-39. PubMed ID: 26450001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
    Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
    Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients.
    Moldovan D; Moldovan I; Rusu C; Kacso I; Patiu IM; Gherman-Caprioara M
    Int Urol Nephrol; 2014 Jan; 46(1):121-8. PubMed ID: 23549862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
    Negishi K; Kobayashi M; Ochiai I; Yamazaki Y; Hasegawa H; Yamashita T; Shimizu T; Kasama S; Kurabayashi M
    Circ J; 2010 Nov; 74(12):2734-40. PubMed ID: 21041973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M; Kirkpantur A; Gulbay M; Gurbuz OA
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis.
    Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
    J Atheroscler Thromb; 2011; 18(3):217-23. PubMed ID: 21139318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure].
    Kutyrina IM; Rudenko TE; Shvetsov MIu; Kushnir VV
    Ter Arkh; 2008; 80(6):37-41. PubMed ID: 18655474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.
    AlHuzaimi A; Al Mashham Y; Potts JE; De Souza AM; Sandor GG
    J Am Soc Echocardiogr; 2013 Sep; 26(9):1084-9. PubMed ID: 23800509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
    Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Echocardiographic evaluation of left ventricular geometry and function in maintenance hemodialysis uremic patients].
    Li AL; Ke YN; Zeng YJ; Li WG; Bian WJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):913-6. PubMed ID: 20137543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.